CPT2 and Hepatic steatosis: EPA-PE significantly increased PPARα protein levels in the liver of healthy mice and increased PPARα and CPT1 protein levels in the liver of rodents with insulin resistance, which alleviated hepatic steatosis and lipid accumulation.